Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.15 - $2.53 $13,092 - $28,804
-11,385 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$1.91 - $3.98 $2,005 - $4,179
1,050 Added 10.16%
11,385 $24,000
Q4 2021

Feb 08, 2022

SELL
$3.53 - $5.5 $10,085 - $15,713
-2,857 Reduced 21.66%
10,335 $38,000
Q3 2021

Nov 02, 2021

BUY
$4.99 - $6.55 $65,828 - $86,407
13,192 New
13,192 $66,000
Q2 2020

Jul 17, 2020

SELL
$2.16 - $5.46 $22,844 - $57,744
-10,576 Closed
0 $0
Q1 2020

Apr 21, 2020

BUY
$1.46 - $7.19 $15,440 - $76,041
10,576 New
10,576 $36,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $264M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.